Scott Biller's most recent trade in Foghorn Therapeutics Inc was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc | Scott Biller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Scott Biller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 16,000 | 16,000 | - | - | Stock Options (Right to buy) | |
| Foghorn Therapeutics Inc | Scott Biller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Scott Biller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 16,000 | 16,000 | - | - | Stock Options (Right to buy) | |
| Foghorn Therapeutics Inc | Scott Biller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 12,530 | 12,530 | - | - | Stock Option (right to buy) |